Skip to main content
OpenTrials
Completed

NCT Number: NCT05405218

Trial of Ultrasound Guided Carpal Tunnel Release Versus Traditional Open Release (TUTOR)

Study to compare the safety and effectiveness of carpal tunnel release with ultrasound guidance (CTR-US) vs. mini-open carpal tunnel release (mOCTR) in patients with symptomatic carpal tunnel syndrome (CTS).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sierra Orthopedic Institute, Sonora, California, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ≥18 years of age
  • Clinical diagnosis of unilateral or bilateral idiopathic CTS
  • CTS-6 score >12 in target hand
  • Absence of carpal tunnel symptoms in the contralateral hand that interfere with normal daily activities or work at the time of consent and are not anticipated to interfere with return to activities or return to work within at least 3 months post-operatively
  • Median nerve cross-sectional area ≥10 mm2 in the proximal carpal tunnel region of the target hand measured by diagnostic ultrasound
  • Prior failure of one or more nonsurgical treatment options for the target hand (e.g., physical activity modification, bracing, splinting, corticosteroid injection)
  • Subject agrees to complete follow-up questionnaires over a 12-month period
  • Subject has a valid mobile phone number and email address to receive and answer follow-up questionnaires

Exclusion criteria

  • Prior surgery on the target wrist or hand with the exception of trigger finger that has clinically recovered
  • History of prior surgical CTR procedure in the target hand
  • History of prior surgical CTR in the contralateral hand within 3 months of enrollment or with persistent symptoms that interfere with normal daily activities or work at the time of consent
  • Corticosteroid injection in the target wrist or hand within 6 weeks of study procedure date
  • Presence of additional process in the target wrist or hand requiring additional intervention beyond carpal tunnel release (e.g. neurolysis, mass removal, tenosynovectomy)
  • Clinically significant degenerative arthritis of the upper limb (shoulder to hand) on the target side
  • Clinically significant inflammatory disease (including tenosynovitis) of the upper limb (shoulder to hand) on the target side
  • Clinically significant trauma or deformity of the upper limb (shoulder to hand) on the target side
  • Clinically significant vascular disease (including Raynaud's phenomenon) of the upper limb (shoulder to hand) on the target side
  • Clinically significant neurological disorder (including complex regional pain syndrome) of the upper limb (shoulder to hand) on the target side
  • Planned surgical or interventional procedure on the contralateral wrist or hand
  • Systemic inflammatory disease (e.g., rheumatoid arthritis, lupus)
  • Amyloidosis
  • Chronic renal insufficiency requiring dialysis
  • Diabetes not controlled by a stable dose of medication over the past three months
  • Uncontrolled thyroid disease
  • Pregnant or planning pregnancy in the next 12 months
  • Workers compensation subjects
  • Inability to provide a legally acceptable Informed Consent Form and/or comply with all follow-up requirements
  • Subject has other medical, social or psychological conditions that, in the opinion of the investigator, preclude them from receiving the pre-treatment, required treatment, and post-treatment procedures and evaluations

Treatment and study plan

CTR with Ultrasound Guidance using the UltraGuideCTR device

Device

Carpal Tunnel Release with Ultrasound Guidance using UltraGuideCTR device

mOCTR

Procedure

Mini Open Carpal Tunnel Release

Primary outcomes

  1. Boston Carpal Tunnel Questionnaire Symptom Severity Scale (BCTQ-SSS) Change

    Time frame: 3 Month Follow-Up

    The Boston Carpal Tunnel Questionnaire Symptom Severity Scale (BCTQ-SSS) is a Carpal Tunnel Syndrome specific questionnaire that has been shown to be highly reproducible, internally consistent, valid, and responsive to clinical change in Carpal Tunnel Syndrome (CTS) and subject status post-carpal tunnel release (CTR). The BCTQ consists of 11 symptom severity questions (BCTQ-SSS). Scoring for the BCTQ- SSS ranges from 1 to 5, with higher scores indicating more severe symptoms, and is calculated as the mean of each response. The mean change scores in BCTQ-SSS from baseline to the 3-month follow-up are reported for each study group. Negative change scores indicate decreased symptom severity and positive change scores indicate increased symptom severity.

  2. Boston Carpal Tunnel Questionnaire Functional Status Scale (BCTQ-FSS) Change

    Time frame: 3 Month Follow-Up

    The Boston Carpal Tunnel Questionnaire Functional Status Scale (BCTQ-FSS) additionally consists of 8 functional status questions. Scoring for the BCTQ-FSS ranges from 1 to 5, with higher scores indicating more functional limitation, and is calculated as the mean of each response. The mean change scores in BCTQ-FSS from baseline to the 3-month follow-up are reported for each study group. Negative change scores indicate decreased functional limitation and positive change scores indicate increased functional limitation.

Other outcomes

  1. Participants With Device or Procedure Related Adverse Events

    Time frame: 3 Month Follow-Up

    Participants with adverse events (AEs) occurring within 90 days of treatment and that are adjudicated as definitely related or probably related to the device or definitely related or probably related to the procedure will be included in this endpoint. The incidence of device- or procedure-related AEs within 90 days of treatment in each study group will represent an endpoint of the study.

  2. Numeric Pain Scale Change

    Time frame: 3 Month Follow-Up

    The Numeric Pain Scale measures pain severity. Scoring for the Numeric Pain Scale ranges from 0 (indicating no pain) to 10 (indicating worst pain possible). The mean change scores in the Numeric Pain Scale from baseline to the 3-month follow-up are reported for each study group. Negative change scores indicate decreased pain severity and positive change scores indicate increased pain severity.

  3. EuroQol 5-Dimension 5-Level (EQ-5D-5L) Change

    Time frame: 3 Month Follow-Up

    The EuroQol 5-Dimension 5-Level (EQ-5D-5L) is a generic preference-based questionnaire developed by the EuroQol Group to measure health-related quality of life. The EQ-5D-5L measures quality of life across 5 domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is scored on a 5-level severity ranking consisting of: no problems, slight problems, moderate problems, severe problems, unable to/extreme problems. Scoring for the EQ-5D-5L ranges from -0.57 (indicating lowest quality of life) to 1.00 (indicating highest quality of life). The mean change scores in the EQ-5D-5L from baseline to the 3-month follow-up are reported for each study group. Negative change scores indicate decreased quality of life and positive change scores indicate increased quality of life.

  4. Time to Return to Work Among Employed Subjects

    Time frame: 3 Month Follow-Up

    The time to return to work will be defined as the number of days between treatment and the time the subject reports returning to work in any capacity.

  5. Participants Who Returned to Normal Daily Activities Within 3 Days Postoperatively

    Time frame: 3 Month Follow-Up

    The time to return to normal daily activities will be defined as the number of days between treatment and the time the subject reports returning to normal daily activities, irrespective of work status.

Sponsors and collaborators

Lead sponsor

Sonex Health, Inc.

Industry

Registry information

Acronym: TUTOR

Important dates

Study start
2022
Primary completion
2023
Study completion
2024
First posted
Jun 6, 2022
Registry last updated
Jun 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.